Drugs / Lanthanum
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT03451019 Comparator | Mar 2018 → Dec 2020 | chronic kidney disease | Medical University of Lodz | Completed | No outcome recorded |
| Phase 4 | NCT03163576 Background | Jun 2017 → Jun 2019 | hyperphosphatemia | Assiut University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lanthanum | “Non-calcium containing phosphate binders, such as sevelamer and lanthanum, are expensive.” NCT03163576 ↗ |
| Known as | Lanthanum Carbonate | “Drug: Lanthanum Carbonate” NCT03451019 ↗ |